123I-vasoactive intestinal peptide (VIP) receptor scanning: update of imaging results in patients with adenocarcinomas and endocrine tumors of the gastrointestinal tract.
Recent data suggest that functional receptors (R) for vasoactive intestinal peptide (VIP) are expressed on various tumor cells. The high-level expression of VIPR on tumor cells provided the basis for the successful use of 123I-labeled VIP for the in vivo localization of intestinal adenocarcinomas and endocrine tumors. We here report an update of our imaging results using 123I-VIP (150-200 MBg/1 microgram/patient) in 169 patients. In patients with pancreatic adenocarcinomas without liver metastases, the primary/recurrent tumor was visualized in 16 of 18 patients (89%) and liver metastases were imaged in 15 of 16 patients. In 11 of 12 patients with colorectal adenocarcinomas, the primary/recurrent tumor (92%) was imaged by 123I-VIP. Also, in 21 of 25 patients, liver metastases (84%); in 3 of 6 patients, lung metastases (50%); and in 4 of 5 patients, lymph-node metastases (80%) were imaged by 123I-VIP. In 10 of 10 patients with gastric adenocarcinomas, the primary/recurrent tumor; in 3 of 4 patients, liver metastases; and in 2 of 2 patients, lymph-node metastases were visualized by 123I-VIP. 123I-VIP localized primary intestinal carcinoid tumors in 15 of 17 patients (88%) and 8 of 10 primary insulinomas (80%). We conclude that the 123I-VIPR scintigraphy localizes intestinal adenocarcinomas and endocrine tumors as well as metastatic tumor sites.
Virgolini
I
I
Department of Nuclear Medicine, University of Vienna, Austria.
Raderer
M
M
Kurtaran
A
A
Angelberger
P
P
Yang
Q
Q
Radosavljevic
M
M
Leimer
M
M
Kaserer
K
K
Li
S R
SR
Kornek
G
G
Hübsch
P
P
Niederle
B
B
Pidlich
J
J
Scheithauer
W
W
Valent
P
P
D000230:Adenocarcinoma / Q000000981:diagnostic imaging* / Q000648:ultrastructure*; D000595:Amino Acid Sequence; D000818:Animals; D019556:COS Cells / Q000000981:diagnostic imaging / Q000648:ultrastructure; D004701:Endocrine Gland Neoplasms / Q000000981:diagnostic imaging* / Q000648:ultrastructure*; D005770:Gastrointestinal Neoplasms / Q000000981:diagnostic imaging* / Q000648:ultrastructure*; D006801:Humans; D007457:Iodine Radioisotopes; D008969:Molecular Sequence Data; D011869:Radioligand Assay; D011877:Radionuclide Imaging; D018005:Receptors, Vasoactive Intestinal Peptide / Q000032:analysis* / Q000378:metabolism; D014660:Vasoactive Intestinal Peptide / Q000378:metabolism*
D007457:Iodine Radioisotopes; D018005:Receptors, Vasoactive Intestinal Peptide; D014660:Vasoactive Intestinal Peptide